skip to Main Content

High Immune Cell Score Predicts Improved Survival in Pancreatic Cancer

Newsfeed image, light gray text on dark gray background
Increasing evidence suggests that cancer progression is strongly influenced by host immune response, which is represented by immune cell infiltrates.

T-lymphocyte-based immunoscore has proved to be a prognostic factor in colon cancer, but its significance in pancreatic cancer is poorly known. Total of 108 patients operated (R0/R1) for pancreatic ductal adenocarcinoma (PDAC) (TNM stage I–II) were included in the study.

Immune cell score (IS) was determined by scoring the samples from grade 0 to 4 according to the number of immune cells (CD3+ and CD8+) in tumor core and invasion margin using tissue microarrays, immunohistochemistry, and digital analysis. Tumors with microsatellite instability were identified by MLH1 immunostaining. Read more . . .

Back To Top